BioLargo, Inc. has been prominently featured in the latest edition of The Disruptive Quarterly, which explores the urgent issue of PFAS (per- and polyfluoroalkyl substances) contamination in water supplies. This feature showcases the company's innovative Aqueous Electrostatic Concentrator (AEC), a significant advancement in water treatment technology aimed at effectively removing these harmful substances.
The Q1/Q2 2026 issue of The Disruptive Quarterly is dedicated to the theme "Water and Our Common Heritage: Facing the Challenge of Forever Chemicals." The edition includes contributions from various experts, including Tonya Chandler, President of BioLargo Equipment Solutions, and a transcript of a keynote address by Dennis Calvert, BioLargo's President and CEO, from a seminar hosted by the Norwegian Embassy in Washington, D.C.
BioLargo's involvement in this special issue underscores its growing influence in discussions about environmental technology and water policy related to PFAS remediation. The publication includes perspectives from environmental attorneys, academic researchers, and industry innovators, highlighting the collaborative efforts required to tackle the challenges posed by forever chemicals.
The Aqueous Electrostatic Concentrator (AEC) employs cutting-edge technology to achieve over 99% efficiency in the removal of PFAS compounds from contaminated water. This patented system operates continuously and utilizes a proprietary membrane system guided by an electrostatic field, resulting in reduced waste compared to traditional methods. BioLargo reports that the operational costs can be as low as 30 cents per 1,000 gallons treated, presenting a cost-effective solution for water treatment.
John Parker, the guest editor of this edition, emphasized the costly legal and technical challenges associated with PFAS, portraying the need for ongoing innovation in the field. Other contributors included experts from academia and industry who offered scientific, policy, and artistic perspectives, reinforcing the anthology's commitment to understanding the implications of clean water preservation.
BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator that focuses on addressing PFAS contamination, advanced water treatment, and various environmental services. It develops and commercialises technologies aimed at improving water quality, controlling odours, and enhancing air quality, among others.
BioLargo's PFAS treatment technology is featured in the Q1/Q2 2026 edition of The Disruptive Quarterly, which discusses challenges related to forever chemicals and clean water protection.
In addition to BioLargo, contributions to The Disruptive Quarterly include various environmental attorneys, academic researchers, and industry innovators, among them Atam P. Dhawan from NJIT and Jeff Denholm from Strong Water Technologies.
The Aqueous Electrostatic Concentrator (AEC) is BioLargo's patented water treatment system designed to effectively remove and concentrate PFAS from contaminated water. It reportedly achieves over 99% PFAS removal while reducing waste and energy costs.
The press release cites several risks including economic conditions affecting purchasing decisions, intense competition in rapidly changing markets, challenges in managing product introductions, and dependence on product distributors' performance.
BioLargo claims that its AEC technology reduces PFAS-laden waste compared to conventional methods and operates at lower energy costs, specifically around 30 cents per 1,000 gallons treated.
BioLargo executives have shared insights through various platforms including the U.S. Department of Commerce's Environmental Technologies Trade Advisory Committee (ETTAC) and the Forbes Business Council, focusing on innovation, sustainability, and environmental issues.
The latest edition of The Disruptive Quarterly, featuring BioLargo, can be accessed at thedisruptivequarterly.com.